Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.275
-0.015-5.17%
Volume:572.99K
Turnover:162.75K
Market Cap:165.11M
PE:-5.53
High:0.295
Open:0.285
Low:0.275
Close:0.290
52wk High:0.665
52wk Low:0.157
Shares:600.40M
Float Shares:467.70M
Volume Ratio:0.58
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.050
EPS(LYR):-0.024
ROE:-594.54%
ROA:-28.84%
PB:-11.19
PE(LYR):-11.63

Loading ...

Company Profile

Company Name:
DIMERIX LTD
Exchange:
ASX
Establishment Date:
- -
Employees:
15
Office Location:
425 Smith Street,Fitzroy,Victoria,Australia
Zip Code:
3065
Fax:
61 8 9388 8256
Introduction:
Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.